Composition : Pitavastatin 2mg + Ezetimibe 10mg
Form : Tablets
/
Pack : 10’s
/
Type : ALU-ALU
Description : Ezetimibe plus statin therapy in ACS patients with dyslipidemia decreased LDL-C and sitosterol levels more than statin therapy solo. Sitosterol Elevation was predictor of poor response to aggressive lipid lowering treatment in ACS patients -
journal of Lipids Volume 2015
Study demonstrated for the first time that co-administration of ezetimibe 10mg enhanced proteinuria-lowering effects of pitavastatin 2mg. in non-diabetic CKD patients partly via a cholesterol-independent manner, Ezetimibe may have pleiotropic actions that could contribute to reno-protective properties of this lipid-lowering agent -
Clinical Pharmacokinetics, May 2005, Volume 44, Issue 5, pp 467-494
View more products with following salts
Ezetimibe Pitavastatin